Betaine Anhydrous Structural Formula (Image 01)
Cystadane Powder, For Solution
Product Images NDC 52276-400
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cystadane (NDC 52276-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Recordati Rare Diseases, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Recordati Rare Diseases Logo (Image 03)
Cystadane® Betaine Anhydrous For Oral Solution Logo (Image 04)
CYSTADANE is an oral solution containing betaine anhydrous that can be used for medical purposes.*
Cystadane (betaine Anhydrous) For Oral Solution Label (Image 05)
Cystadane is an oral solution containing 1 gram of betaine anhydrous powder per scoopful. It is used to treat rare diseases and is licensed to Recordati Rare Diseases Inc. in the USA. The dosage and administration instructions can be found in the package insert, and the medication should be kept out of reach of children, in a tightly capped, room temperature area protected from moisture. The manufacturing date of the product is April 2019, and it is made in Germany.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
